<p>Insights into Chronic Obstructive Pulmonary Disease as Critical Risk Factor for Cardiovascular Disease</p>-Reference-Cited by-同舟云学术

Insights into Chronic Obstructive Pulmonary Disease as Critical Risk Factor for Cardiovascular Disease

Published:2020-04 Issue: Volume:Volume 15 Page:755-764
ISSN:1178-2005
Container-title:International Journal of Chronic Obstructive Pulmonary Disease
language:en
Short-container-title:COPD

Author:

Almagro Pere^ORCID,Boixeda Ramon^ORCID,Diez-Manglano Jesús^ORCID,Gómez-Antúnez María,López-García Franciso,Recio Jesús^ORCID

Publisher

Informa UK Limited

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pulmonary and Respiratory Medicine,General Medicine

Reference86 articles.

1. (WHO) 1. World Health Organization. Chronic obstructive pulmonary disease (COPD). 1 December 2017. Key facts. Available from: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd). Accessed July 22, 2019.

2. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

3. Clusters of Comorbidities Based on Validated Objective Measurements and Systemic Inflammation in Patients with Chronic Obstructive Pulmonary Disease

4. Epidemiology and clinical impact of major comorbidities in patients with COPD

5. Prevalence of comorbidities in chronic obstructive pulmonary disease patients

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases;Metabolism;2024-10

2. Is ‘Cardiopulmonary’ the New ‘Cardiometabolic’? Making a Case for Systems Change in COPD;Pulmonary Therapy;2024-09-09

3. Breaking down barriers to COPD management in primary care: applying the updated 2023 Canadian Thoracic Society guideline for pharmacotherapy;Frontiers in Medicine;2024-08-06

4. COPD is associated with increased cardiovascular disease risk independent of phenotype;Respirology;2024-07-17

5. Cardiovascular disease and risk in COPD: a state of the art review;Expert Review of Cardiovascular Therapy;2024-03-27